EL MONTE, Calif., May 6, 2025 /PRNewswire/ — As a leader in e-trike innovation and the brand with the widest selection of electric trikes in the U.S., Addmotor is proud to announce the launch of its 2025 Electric Trike series, designed to enhance mobility and expand consumer choices in eco-friendly transportation.

The 2025 lineup, which includes the Citytan Folding, SpytanX Reverse, Greattan D Fat Tire, M-380 Tandem models, and Addmotor customized accessories, offers unparalleled versatility, meeting the needs of urban commuters, families, and golf enthusiasts alike. With a focus on cutting-edge design, advanced technology, and user-centric features, Addmotor continues to redefine the future of electric mobility.

Citytan – Foldable e-Trike

Citytan redefines the concept of the most affordable electric folding trike. With its entire frame composed of aluminum, the Citytan offers improved durability and minimizes the risk of frame distortion, ensuring a safe and long-lasting ride. Its foldable step-through frame and handlebar stem make it incredibly easy to store in tight spaces such as cars, RVs, or any area with limited room, enhancing portability for riders on the go.

Compared to the Addmotor Citytri, which is equipped with city tires, the Citytan comes with wider 3-inch mini fat tires, offering more tire surface area for improved stability and versatility across different terrains. Whether you’re navigating city streets or taking light uneven paths, these tires ensure a smoother, more secure ride.

The 14.1-inch low step-through frame makes mounting and dismounting effortless, catering to adults of all fitness levels. With its user-friendly design and ease of use, the Citytan is perfect for those seeking both comfort and practicality.

Priced at $1,699, the Citytan becomes even more accessible with a $300 pre-sale discount, bringing the limited-time price down to just $1,399—proving that a high-quality e-trike doesn’t have to break the bank.

Addmotor also offers the Non-Electric Citytan M-315 Traditional Trike, originally priced at $699, now available for pre-order at just $499, saving you $200. This trike provides many of the same benefits as the Citytan E-Trike, including a lightweight, folding all-aluminum frame, wide 3-inch tires, and low step-through design, to name a few. It’s an affordable option for those who prefer a more traditional, non-electric experience.

SpytanX – Reverse e-Trike

SpytanX is designed with golf lovers and pet lovers in mind, offering a fresh and convenient way to navigate the golf course or daily rides. Powered by a 750W motor and a 960Wh UL 2271 certified battery, this e-trike delivers both power and reliability, ensuring a smooth and comfortable ride on and off the course. Its dual front-wheel layout enhances stability, while providing a spacious front basket that’s perfect for carrying groceries, pet carriers, or personal items. Riders can easily keep their belongings and pets in view without the need to constantly look back, improving safety and allowing for more interaction with your furry companions.

To cater to golf enthusiasts, Addmotor has specially designed SpytanX with a stand front rack that can hold a golf bag. Now, you can enjoy your game without any distractions, knowing that your gear is securely in place. 

With its upgraded front suspension and an advanced 16-connecting-rod steering system, the SpytanX delivers an unmatched riding experience, making it the perfect choice for those seeking the pinnacle of reverse tricycle performance.

M-380 – Tandem E-Trike

The M-380 Tandem E-Trike is built for shared exploration, transforming the way two riders experience the joy of cycling together. Featuring two comfortable seats—the rear seat with a supportive backrest—and pedals, this electric trike allows both riders to actively participate in pedaling, unlike traditional passenger e-trikes.

What sets the M-380 apart is its advanced drivetrain system, which enables the front and rear riders to control their own pedals independently. The rear seat is even suitable for riders with disabilities or children, providing extra comfort and ease for those who might find it difficult to ride independently. This design ensures that riders of different fitness levels can enjoy the ride together—faster riders don’t need to wait for slower riders, and slower riders won’t feel the strain of trying to keep up. Each rider can enjoy the joy of cycling at their own pace, creating a truly cooperative cycling experience. 

Plus, M-380 trike includes a torque sensor on the front pedal-assist system, enabling the front rider to adjust the motor’s power based on pedaling force. This feature makes the ride more responsive, efficient, and in control, enhancing the overall enjoyment.

The optional dual-battery system enhances the M-380’s performance and range, giving riders the flexibility to choose between a single or dual-battery configuration to best suit their needs. Whether cruising through the city or embarking on a longer adventure, the M-380 offers the power you need. Its 38.5-inch widened rear track enhances stability, reducing the risk of tipping, especially with its elongated trike frame. Paired with a 750W motor, the M-380 can support up to 500 lbs of combined rider and cargo weight, making it a reliable option for various needs.

With these thoughtful features, the M-380 Tandem E-Trike is the perfect solution for sharing the ride—whether for an additional disabled rider, a child, or anyone who enjoys exploring together, all while benefiting from the best in modern e-trike technology.

Greattan D – Fat Tire & Cargo E-Trike

Greattan D is the ultimate multi-purpose cargo e-trike, designed to redefine the versatility of fat tire electric trikes. Built for heavy-duty tasks, this e-trike features 7-inch rear fat tires that not only provide superior traction on both smooth city streets and rough, uneven terrains but also offer remarkable load-bearing capacity. These robust tires can support heavy weight without compromising stability or performance.

Capable of supporting up to 500 lbs of total weight, the Greattan D is a solid e-trike for transporting heavy items. Its extra-large rear cargo basket, with a capacity of up to 150 lbs, is perfect for work equipment, groceries, or camping gear. To ensure this impressive payload capacity is met with reliable durability, the rear axle is 25% thicker than other models on the market and has been reinforced to prevent damage during transport.

The performance of the Greattan D is equally as impressive. Powered by a 750W rear-drive motor and an optional dual-battery system, it easily conquers challenging terrains and heavy loads. Whether you’re tackling long-distance journeys or managing daily heavy-duty errands, the Greattan D offers the power and range you need to go the distance without worrying about running out of energy.

Addmotor Customized Accessories for Every Lifestyle

1. Smart Cycling Helmet

Addmotor Smart Cycling Helmet combines safety, connectivity, and comfort to enhance your riding experience. Featuring advanced light modes for increased visibility, live intercom and hands-free calling via the Addmotor APP, and multimedia integration for music and audio notifications, this smart helmet ensures a secure and enjoyable ride. With its durable construction, optimized airflow system, and innovative app-enabled features, this Addmotor helmet is the perfect companion for modern cyclists seeking both functionality and style.

2. Trike Trailer – America’s First Trike-Ready Trailer

Addmotor Trike Trailer is the first trailer in the U.S. specifically designed for electric tricycles. With its innovative design, this trailer attaches centrally to the rear of the tricycle, minimizing the potential for instability, ensuring a smooth and secure ride even when carrying heavy loads.

The true versatility of the Addmotor Trailer lies in its compatibility with all Addmotor electric trikes and electric bicycles with 20-inch and 26-inch wheels, when paired with the appropriate adapter. With a maximum load capacity of 220 lbs, the Addmotor Trike Trailer allows you to carry everything from camping gear to groceries or work equipment. The trailer frame is designed to be removable and customizable, making it easy to store and adapt to your specific needs. Whether you’re embarking on a long journey or simply need extra space for your daily tasks, this trailer offers the flexibility and durability you need for all types of adventures.

3. Pet Carrier

Addmotor introduces the Addmotor pet carrier in acknowledgment of the special bond between riders and their furry friends. It fits seamlessly on most Addmotor e-trikes. Built with waterproof and scratch-resistant nylon fabric, this carrier ensures your pet enjoys a cozy, safe ride by your side. Its breathable mesh design keeps your companion happy while allowing you to keep an eye on them throughout the journey.

For added safety, the pet carrier features a reflective strip on the back, making you and your pet more visible to others during low-light conditions. The carrier is easy to install and includes two openings, allowing your pet to get in and out easily from either side. When not in use, the frame of the pet carrier can be collapsed for convenient storage.

About Addmotor

As one of the pioneering brands in the electric trike market, Addmotor continues to set trends in both design and functionality. Addmotor 2025 collection reflects a deep understanding of user feedback and modern consumer trends and an unwavering focus on delivering the best riding experience. Each product demonstrates the brand’s commitment to expanding the practicality and versatility of its electric trikes for multiple demographics, from urban commuters and couples to golf enthusiasts, families, and pet owners. Yet again, Addmotor proves that sustainable travel can be both functional and enjoyable.

For complete technical specifications and more information on Addmotor latest electric trike models 2025, or to find your local authorized Addmotor store, visit addmotor.com.

Media Contact

Mobile no.: +1 888-660-0868

Email address: Press@addmotor.com 

Website: https://www.addmotor.com/

Rodrigo Jimenez to pick up Asia Pacific reins from Paul Flanagan

HONG KONG, May 6, 2025 /PRNewswire/ — Allianz Trade in Asia Pacific is pleased to announce that Rodrigo Jimenez will take on the role of Asia Pacific Regional CEO on 1 October 2025. He will succeed Paul Flanagan who is retiring after a 34-year career with the global leader in trade credit insurance. Mr Jimenez will begin a three-month transition period from 1 July 2025 and officially take over the helm on 1 October 2025. This appointment is subject to standard regulatory approval requirements.

Mr Jimenez joined Allianz Trade in Brazil as CEO in 2014. Since 2021, he has been Regional Commercial Director for the Northern Europe region and being part of the Regional Management Team. In this role, he has developed and strengthened new distribution dynamics and strong synergies with the Risk department, which have in turn supported new business development and portfolio retention. He is also a keen advocate of digital transformation and has been closely involved in a number of crucial transformation projects in the Northern Europe region. Mr Jimenez holds an MBA degree from the Fundação Dom Cabral and a degree in Economics from the University of Sao Paulo.

On his appointment, Mr Jimenez says, “It is an incredibly exciting time to be joining the Asia Pacific region. I am inspired by the growth Asia Pacific has already achieved and the transformative journey ahead, with plans to extend our presence to Vietnam, the thirteenth market in the region. Paul has set the bar high, establishing a solid foundation for this expansion, based on an unwavering commitment to customer experience and operational excellence. I look forward to continuing this mission, reinforcing our leadership position and driving innovation that delivers lasting value to our clients and partners across the region. I would like to congratulate Paul on an exemplary 34-year career at Allianz Trade and wish him every happiness in his retirement.”

About Allianz Trade

Allianz Trade is the global leader in trade credit insurance and a recognized specialist in the areas of surety, collections, structured trade credit and political risk. Our proprietary intelligence network is based on instant access to data of 289 million corporates. We give companies the confidence to trade by securing their payments. We compensate your company in the event of a bad debt, but more importantly, we help you avoid bad debt in the first place. Whenever we provide trade credit insurance or other finance solutions, our priority is predictive protection. But, when the unexpected arrives, our AA credit rating means we have the resources, backed by Allianz to provide compensation to maintain your business. Headquartered in Paris, Allianz Trade is present in over 40 countries with 5,800 employees. In 2024, our consolidated turnover was EUR3.8 billion and insured global business transactions represented EUR1,400 billion in exposure. For more information, please visit allianz-trade.com

Expanding from six to seven properties in Asia Pacific, the 2025 series will offer a gastronomic reinterpretation of traditional flavors and forgotten ingredients

SINGAPORE, May 6, 2025 /PRNewswire/ — Following last year’s tremendous success, The Luxury Group by Marriott International is proud to announce the highly anticipated return of the Luxury Dining Series. Taking place from July to September, the multi-city regional dining series in 2025 continues to invite discerning travelers and dining enthusiasts to embark on an extraordinary gastronomic journey celebrating the revival of lost flavors and culinary traditions.  

Inspired by the findings from the Future of Food 2025 report, this year’s theme of Forgotten Flavors celebrates the art of culinary history and will explore time-honored techniques and innovative culinary experimentation at seven handpicked hotels. The locations of the 2025 series include The St. Regis Osaka, JW Marriott Jeju Resort & Spa, JW Marriott Bengaluru Prestige GolfshireResort & Spa, The Ritz-Carlton, Perth, The St. Regis Singapore, The St. Regis Jakarta, and the newly opened The Ritz-Carlton, Bangkok.   

Renowned chefs and mixologists from across Marriott International’s global portfolio will unite, pairing masters of tradition with contemporary visionaries, to resurrect lost, neglected, and overlooked ingredients. Guests can look forward to a carefully curated gastronomic experience where every plate will offer a taste of the past, reimagined for today’s palate.  

 The full schedule of the series is as follows: 

• Japan – July 11-13 – The St. Regis Osaka 
• Korea – July 17-20 – JW Marriott Jeju Resort & Spa 
• India – July 31- August 3 – JW Marriott Bengaluru Prestige Golfshire Resort & Spa
• Australia – August 15-17 – The Ritz-Carlton, Perth 
• Singapore – August 29-31 – The St. Regis Singapore 
• Indonesia – September 11-13 – The St. Regis Jakarta
• Thailand – September 25-28 – The Ritz-Carlton, Bangkok 

More details on programming will be announced soon. Please visit the website for more information – https://www.marriott.com/en-us/marriott-brands/portfolio/luxury-dining-series.mi   

Video and high-resolution images can be downloaded here 

About Marriott International 

Marriott International, Inc. (Nasdaq: MAR) is based in Bethesda, Maryland, USA, and encompasses a portfolio of over 9,300 properties across more than 30 leading brands in 144 countries and territories. Marriott operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties all around the world. The company offers Marriott Bonvoy^®, its highly awarded travel platform. For more information, please visit our website at www.marriott.com, and for the latest company news, visit www.marriottnewscenter.com. In addition, connect with us on Facebook and @MarriottIntl on X and Instagram.  

About Luxury Group by Marriott International 

With an unrivaled portfolio of eight dynamic luxury brands, Marriott International is creating authentic, rare, and enriching experiences sought by today’s global luxurian. Spanning all corners of the world, Marriott International’s Luxury Group offers a boundless network of more than 530 landmark hotels and resorts in over 70 countries and territories through The Ritz-Carlton, Ritz-Carlton Reserve, Bvlgari Hotels & Resorts, St. Regis Hotels & Resorts, EDITION, The Luxury Collection, JW Marriott, and W Hotels. From the world’s most iconic destinations to the ultimate undiscovered gems, the international hospitality leader’s collection of luxury brands is focused on elevating travel with highly contextualized, nuanced brand experiences that signal the future of luxury by allowing guests to indulge their passions while sparking personal growth.  

Media Contact

Joanna Huang
Director, Luxury PR & Communications
Marriott International, Asia Pacific excluding China
joanna.huang@marriottluxurybrands.com

–  Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund

– Proceeds will support the Phase 1/2 clinical trial of lead candidate, NVC-001, in patients with LMNA-related dilated cardiomyopathy (LMNA DCM) through to clinical proof-of-concept

SINGAPORE and PHILADELPHIA, May 6, 2025 /PRNewswire/ — Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the successful completion of US$45 million Series B financing. The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund, alongside Highlight Capital and SEEDS Capital. Nuevocor is pleased to welcome Amanda Gett-Chaperot, PhD (Kurma Partners) and Elia Stupka, PhD (Angelini Ventures) to its Board of Directors.

The new investment will support a first-in-human, open-label, multicenter, ascending single-dose Phase 1/2 clinical trial of NVC-001 in patients with LMNA DCM, with clinical trial sites across the U.S. and Europe. Additionally, the company will establish an office in Paris, France, to support clinical development and bring Singapore innovation to patients globally.

LMNA DCM is a genetic heart condition caused by mutations in the LMNA gene, leading to the weakening and enlargement of the heart muscle, ultimately resulting in a rapid progression toward end-stage heart failure. LMNA DCM is estimated to affect more than 100,000 patients in the U.S. and Europe. NVC-001 and other pipeline assets are derived from Nuevocor’s proprietary PrOSIA^TM mechanobiology platform, which pinpoints the functional root-cause of many cardiomyopathies.

“We are delighted to secure this significant financing milestone to build a global company with such an experienced syndicate of international life science investors,” said Dr. Yann Chong Tan, PhD, CEO and Co-Founder of Nuevocor. “The continued strong support from insiders and the addition of new investors will enable Nuevocor to continue its strong momentum and advance NVC-001 into the clinic. This is an example of how Singapore is bringing transformative innovation to the rest of the world.”

“Nuevocor is providing new hope to a significant population of cardiovascular patients who today lack treatment options by directly targeting the underlying causes of disease,” said Dr. Amanda Gett-Chaperot, Partner at Kurma Partners. “The burden of cardiomyopathies is large, and Kurma is excited to join Nuevocor, investing from our new Biofund IV to create meaningful value through the treatment of these important diseases.”

“Our investment in Nuevocor marks a strategic expansion for Angelini Ventures – into cardiovascular disease, gene therapy, and the Singapore biotech ecosystem. We are excited by Nuevocor’s novel approach to treating genetic-dilated cardiomyopathy by targeting mechanobiological pathways rather than simply replacing genes. This one-time therapy has the potential to transform patient outcomes and ease healthcare burdens. We are proud to support their mission and join the Board, alongside Kurma, ClavystBio, EDBI, Boehringer Ingelheim Venture Fund, and other investors, as the company grows globally, including into Europe,” said Dr.Elia Stupka, Managing Director at Angelini Ventures.

About NVC-001

NVC-001 is a first-in-class, AAV-based gene therapy candidate for the treatment of LMNA-related dilated cardiomyopathy (LMNA DCM), one of the most aggressive forms of  DCM with a rapid progression toward end-stage heart failure and malignant ventricular arrhythmias associated with increased risk of sudden cardiac death. LMNA DCM is estimated to affect more than 100,000 patients in the U.S. and Europe. NVC-001 is designed to reduce forces to the nucleus to restore nuclear envelope integrity, a hallmark of LMNA DCM, and treat disease. NVC-001 has demonstrated dramatic survival benefits in preclinical models, high transduction levels and a clean safety profile in both GLP toxicology studies and large animal models. Nuevocor plans to initiate a Phase 1/2 clinical trial in early 2026, with sites in the U.S. and Europe, and a concurrent natural history study.

About Nuevocor

Nuevocor is an IND-stage biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, headquartered in Singapore with an office in the U.S. and expanding to Europe. Our unique approach, enabled by our proprietary PrOSIA^TM mechanobiology platform, surpasses the limitations of traditional gene replacement therapy – which treats individual gene mutations – to treating defects in shared disease pathways across multiple cardiomyopathies by addressing the root cause of disease. Nuevocor is first-in-disease by addressing genetic cardiomyopathies that are not amendable to gene replacement therapy and have no effective treatment options. (www.nuevocor.com)

About Kurma Partners

Founded in 2009 in Paris, Kurma Partners has become a key player in Europe, financing innovation to build the healthcare industry of tomorrow. Kurma invests from company formation to growth capital, across the spectrum of healthcare through specialized franchises. The franchises continue to expand with successive funds focused on biotechnology (Biofunds I, II, III, IV), digital health & diagnostics (Kurma Diagnostics and Kurma Diagnostics 2) and more recently, growth opportunities (Kurma Growth Opportunity Fund). Kurma’s teams based in Paris and Munich are embedded within the European ecosystem and have strong international networks spanning prestigious research institutes and hospitals, entrepreneurs, industry and investors. Kurma Partners is part of the Eurazeo group. (www.kurmapartners.com)

About Angelini Ventures

Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in biotech and digital health. Angelini Ventures will invest €300 million across a global portfolio, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies. To date, Angelini Ventures has invested around €100 million into 18 companies covering a range of therapeutic areas and modalities. Its biotech portfolio includes Neumirna, Cour Pharmaceuticals, Nouscom, Pretzel Therapeutics and Freya Biosciences. The digital health portfolio includes Vantis Health, Avation, Cadence Neuroscience, Nobi, Noctrix and Serenis. (www.angeliniventures.com)

About EDBI

EDBI operates under SG Growth Capital, the investment platform of the Singapore Economic Development Board (EDB) and Enterprise Singapore. We invest in high-growth global technology companies and industry leaders looking to scale in Singapore and across Asia. Leveraging SG Growth Capital’s extensive networks and expertise, we collaborate with our portfolio companies to unlock growth opportunities, create pathways for advancement, and connect them with the resources needed for success. Through strategic investments and partnerships, we drive the development of innovative solutions, create good jobs, and contribute to Singapore’s long-term economic resilience. (www.edbi.com/) 

About ClavystBio

ClavystBio is a life sciences investor and venture builder established by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with innovators, entrepreneurs and founders to launch and grow global companies from Singapore. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing startups together, we foster a vibrant and supportive community. Since our inception in 2022, ClavystBio has committed over US $220 million in investments in the life sciences sector. (www.clavystbio.com)  

About Boehringer Ingelheim Venture Fund

The Boehringer Ingelheim Venture Fund (BIVF), established in 2010, is dedicated to investing in groundbreaking biotechnology companies that are at the forefront of therapeutic and digital innovations, aiming to advance biomedical research. With a commitment to revolutionizing the standard of care, the BIVF fosters long-term partnerships with scientists and entrepreneurs. The BIVF’s focus is on nurturing disease-modifying therapeutic concepts and facilitating their clinical application. The BIVF prioritizes the translation of first-in-class concepts that address significant medical needs in fields such as oncology, immunology, regenerative medicine, neurodegeneration, infectious diseases, and digital health technologies. These innovative concepts often encompass novel platform technologies designed to tackle targets and diseases that were previously considered untreatable. With a fund volume of EUR 350 million, the BIVF operates as an evergreen fund, continually reinvesting to fuel its mission. The partners of the BIVF gain from the fund’s deep expertise in drug discovery & development, translational science, and management, along with access to a network of experts within the Boehringer Ingelheim organization. Currently, the BIVF supports a diverse portfolio of over 40 companies, leveraging its extensive experience to drive progress in healthcare. (www.boehringer-ingelheim-venture.com)

SINGAPORE, May 6, 2025 /PRNewswire/ — Presenting fatherhood as cool, admirable and masculine is likely to headline a new fertility rebound initiative across the Asia Pacific region as birth rates continue to fall at alarming levels.

Renowned reproductive endocrinologist Emeritus Professor Dominique de Ziegler said a “gender revolution” had seen increasing numbers of women delaying motherhood to enter the public sector in pursuit of professional careers.

“The fact is that for many of these women attempts to start a family may be delayed to their thirties and early forties when their fertility is in sharp decline,” he said.

“To address this reality, family building strategies should focus on encouraging men into the private sphere by promoting active fatherhood and recognising that childcare is not only a mother’s job.”

Professor de Ziegler is Co-Chair of a new Population Sustainability action group of the Asia Pacific Initiative on Reproduction (ASPIRE), the peak regional body for scientists, clinicians, nurses and counsellors in assisted reproduction.

Speaking at the ASPIRE 2025 Congress in Singapore, Professor de Ziegler, said fertility decline resulted from two distinct causes.

“Some couples do not want to have children while for others the ultimate family size ends up being smaller than desired,” he explained.

“Numerous social measures are being advocated to increase birth rates by lowering the financial burden of raising a family. 

“Assisted reproductive technology can also help reduce the gap between the desired and actual family size by favouring fertility preservation through egg and embryo freezing.

“But generating a fertility rebound should include redefining the role of fatherhood and including men more centrally in the family.

“This is already happening in Japan where companies are being rewarded for actively supporting fatherhood and fathers are being promoted as role models in enjoying child rearing.”

Professor de Ziegler is based in Cambodia where he has long experience is social and family issues. He is also a reproductive specialist at the Foch Assisted Reproductive Technology Centre in France.

He said the ASPIRE special interest group on population sustainability was harnessing experts in a range of disciplines, including medicine and economics, to consider evidence-based insights and family building strategies with the intention of presenting recommendations to governments and policy makers.

“Countries in the Asia Pacific region will be central to our endeavours because this part of the world is the most severely concerned by issues related to fertility decline and its consequences,” Professor de Ziegler added.